𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression and Antitumor Effects of TRAIL in Human Cholangiocarcinoma

✍ Scribed by Shinji Tanaka; Keishi Sugimachi; Ken Shirabe; Mitsuo Shimada; Jack R. Wands; Keizo Sugimachi

Book ID
111721328
Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
270 KB
Volume
32
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Enhanced expression of thrombospondin-1
Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma
✍ Naoyuki Kawahara; Mayumi Ono; Ken-ichi Taguchi; Masahiro Okamoto; Mitsuo Shimada πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 596 KB

Cholangiocarcinoma (CCC) is relatively hypovascular, in contrast to hepatocellular carcinoma (HCC), which is often highly vascular. We investigated if the diminished vascularity of CCC is related to altered expression of thrombospondin-1 (TSP-1), an antiangiogenic factor, and/or vascular endothelial

Functional expression of TRAIL and TRAIL
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development
✍ Elisabetta Melloni; Paola Secchiero; Claudio Celeghini; Diana Campioni; Vittorio πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 391 KB

## Abstract The expression and function of surface TRAIL and TRAIL receptors were investigated in primary megakaryocytic cells, generated in serum‐free liquid phase from peripheral human CD34^+^ cells. The surface expression of both TRAIL and β€œdeath receptor” TRAIL‐R2 became detectable starting fro